Profound Medical (PRN) Price, Holdings, & News

ETF Overview

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Key Stats

• Today's Range: C$5.75 to C$6.19
• 50-Day Range: C$5.75 to C$8.23
• 52-Week Range: C$5.58 to C$12.74
• Volume: 19,612 shs
• Average Volume: 7,935 shs
• Market Capitalization: C$172.80 million
• Assets Under Management: C$131.70 million
• Dividend Yield: 9.91%
• Net Expense Ratio: 0.60%
• Aggregate Rating: Moderate Buy

PRN ETF - Frequently Asked Questions

How have PRN shares performed this year?

Profound Medical's stock was trading at C$10.80 at the start of the year. Since then, PRN shares have decreased by 46.8% and is now trading at C$5.75.

How were Profound Medical's earnings last quarter?

Profound Medical Corp. (TSE:PRN) released its quarterly earnings results on Thursday, November, 7th. The company reported ($0.52) earnings per share for the quarter, missing the consensus estimate of ($0.42) by $0.10. Profound Medical had a negative trailing twelve-month return on equity of 85.22% and a negative net margin of 349.41%.

How do I buy shares of Profound Medical?

Shares of PRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Profound Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Profound Medical investors own include 10094 (IRD.TO) (IRD), Profound Medical (PROF), Whitecap Resources (WCP), Air Canada (AC), AXT (AXTI), Bank of Nova Scotia (BNS) and Enbridge (ENB).

Fund Details

• Issuer: Invesco
• Fund Name: Invesco DWA Industrials Momentum ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: TSE
• Current Symbol: TSE:PRN
• Inception Date: 10/12/2006
• Fund Manager: Peter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon
• Web: www.profoundmedical.com
• Phone: 647-476-1350

Fund Focus

• Asset Class: Equity
• Benchmark: DWA Industrials Technical Leaders Index
• Category: Sector
• Focus: Industrials
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 45

Fund Statistics

• Assets Under Management: $131.70 million
• Average Daily Volume: $18.99 thousand
• Discount/Premium: -0.74%

Administrator, Advisor and Custodian

• Administrator: The Bank of New York Mellon Corporation
• Advisor: Invesco Capital Management LLC
• Custodian: The Bank of New York Mellon Corporation
• Distributor: Invesco Distributors, Inc.
• Transfer Agent: The Bank of New York Mellon Corporation
• Trustee: N/A
• Lead Market Maker: Susquehanna

Miscellaneous

• Outstanding Shares: 30,053,000
• Beta: -0.25
• Creation Unit: 50,000
• Creation Fee: $500.00